RxDoctor Payments Data

Melissa Brian, NP

Psychiatric/Mental Health · Youngstown, OHNPI 1669937108

Payments from drug & device makers

$1,205in general payments, 2019–2025

Across 55 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$347
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$204
  • Lundbeck LLC$153
  • Supernus Pharmaceuticals, Inc.$149
  • Corium, LLC$104
  • AbbVie$94
  • plus $155 from 6 others

What the payments were for

  • Food & beverage$1,15696%
  • Education$494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,205 in reported general payments places this provider in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$11,198
Medicare patients
24
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$25,647
RexultiBrexpiprazole16$23,233
VyvanseLisdexamfetamine Dimesylate20$12,460
TrintellixVortioxetine Hydrobromide26$11,297
Aripiprazole110$3,095
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine103$2,939
Quetiapine Fumarate122$1,870
Paliperidone ErPaliperidone18$1,867
Duloxetine Hcl96$1,865
Olanzapine26$1,564
Clozapine24$1,495
Mirtazapine92$1,469
Fluvoxamine Maleate25$1,259
Clonazepam128$1,178
Divalproex Sodium41$916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$21$25,64711 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix$22$23,75746 claims
Otsuka America Pharmaceutical, Inc.Rexulti$347$23,23316 claims
Almatica Pharma LLCSertraline Hcl$54$40084 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →